CLINICAL_TRIALS
trial_result
· 2022-12-15
Clinical Trial Update: Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension [Phase 4]
Summary
Phase 4 trial evaluating the effects of treprostinil on right ventricular structure and function in patients with pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Magdi H. Yacoub | Conditions: Pulmonary Hypertension | Phase 4 | Status: UNKNOWN